ST. Louis Neurontin Attorneys, Pharmaceutical Attorneys - Brown & Crouppen - Client Profile

The law firm of Brown & Crouppen, LLP, has developed a Neurontin & Pharmaceutical Legal Assistance Web site for anyone who has suffered the many serious side effects associated with Neurontin and wants to learn more about the drug, or who wishes to explore their legal options. Founding attorneys Ron Brown and Terry Crouppen have represented many people who have been prescribed Neurontin, and clients are backed by a team of legal professionals, medical experts and investigators who are committed to ensuring that their rights are protected.

Recent lawsuits against Neurontin manufacturer Pfizer Inc. - and its subsidiary, Warner-Lambert – reveal the extent to which the company circumvented FDA regulations by paying doctors tens of thousands of dollars to promote and prescribe Neurontin for scientifically unproven “off-label” uses, based on faulty drug trial results. Pfizer has stated that off-label uses account for 80 percent of Neurontin prescriptions. While it is not illegal for a doctor to prescribe Neurontin for “off-label” medical conditions, it is illegal for the pharmaceutical manufacturer to promote a dangerous drug for unapproved uses.

Brown & Crouppen’s Neurontin & Pharmaceutical Legal Assistance Web site was conceived by the Brown & Crouppen firm, which has more than 70 talented legal professionals in four Missouri locations and Fairview Heights, Ill. The Neurontin & Pharmaceutical Legal Assistance Web site was developed to serve as the primary source for information and communication for people who have suffered because of the prescription drug Neurontin. In addition to sections that focus on Neurontin, What You Should Know, Neurontin Side Effects, Dangers and FAQs, an online evaluation form, developed by Brown & Crouppen, guides the visitor through providing the information needed to determine whether users of Neurontin have legal rights that might entitle them to compensation.

Brown & Crouppen and Consultwebs brought the concept for the site to reality by helping develop a site rich in facts, information and resources. Consultwebs and Brown & Crouppen researchers utilized paid and non fee-based Web sources, as well as physician consultation to develop a site filled with practical information that educates, informs and promotes interaction between Neurontin patients who have filed suits against Pfizer Inc. for their serious and often life-threatening side effects.

In addition to site design, coding, research and content development assistance, Consultwebs optimized the site to attract Web traffic. According to Dale Tincher, president and managing partner for Consultwebs, “The mentality of ‘if you build it, they will come’ simply does not hold true in the Internet environment. The only way to put information in the hands of those who need it is by attracting visitors and keeping them interested in what a Web site has to say. Multitudes have been affected by the scourge of this type of prescription drug abuse, so we felt that it was critical to make the Brown & Crouppen Neurontin campaign successful.”

For almost a quarter of a century, the Brown & Crouppen law firm has been building a reputation for success with personal injury clients throughout Missouri. Ron Brown and Terry Crouppen, the firm’s founders, attribute their extraordinary growth to client satisfaction and quality relationships. As the firm has gained prominence, the Brown & Crouppen team has grown to more than 70 legal professionals located throughout the St. Louis and Metro East area of Missouri and Fairview Heights, Illinois. The entire team shares a mutual vision of delivering the best possible service to clients and making a real difference in people’s lives.

For more information, please contact Brown and Crouppen or Consultwebs.com, Inc.

Top of Page

Contact Lens Moisture Plus

Neurontin Lawyers

Neurontin Information

Oxycontin Lawyers

Oxycontin Information

Prempro Lawyers

Prempro Information

Legal Resource Links

Avandia Lawsuits

Gardasil

Gadolinium Lawsuit